Therapeutic Protein Drug Products

Therapeutic Protein Drug Products

Practical Approaches to formulation in the Laboratory, Manufacturing, and the Clinic

1st Edition - January 2, 2012

Write a review

  • Editor: Brian Meyer
  • Hardcover ISBN: 9781907568183
  • eBook ISBN: 9781908818102

Purchase options

Purchase options
Available
DRM-free (PDF, Mobi, EPub)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Therapeutic protein drug products provides a comprehensive overview of therapeutic protein drug products, with an emphasis on formulation beginning in the laboratory, followed by manufacturing and administration in the clinic. A list of many commercial therapeutic drug products are described and include the product name, dosages, active concentration, buffer, excipients, Ph, container type and route of administration. The laboratory formulation sections focus on the most common buffers, excipients, and Ph ranges that are commonly tested in addition to systematic approaches. A brief section on biophysical and analytical analysis is also provided. Properties of therapeutic protein formulations are described and include opalescence, phase separation, color, and subvisible particles. An emphasis is placed on material and process testing to ensure success during manufacturing. The drug product manufacturing process, which includes the process of compounding to filling, is also covered. Methods of delivery in the clinic are addressed, as well as delivery strategies. Finally, a perspective on the regulatory requirements for therapeutic protein formulations is discussed.

Key Features

  • Provides a list and description of commercially available therapeutic drug products and their formulations
  • A comprehensive and practical overview of protein formulation in the laboratory, manufacturing, and the clinic
  • Discusses recent topics including high protein concentration, phase separation, opalescence, and subvisible particles

Readership

The pharmaceutical and biotechnology industries

Table of Contents

  • List of figures and tables

    Preface

    About the authors

    Chapter 1: Commercial therapeutic protein drug products

    Abstract

    1.1 Introduction

    1.2 Lyophilized formulations

    1.3 Liquid formulations

    1.4 Protein formulations for radiologic and diagnostic use

    1.5 Summary

    Chapter 2: A formulation method to improve the physical stability of macromolecular-based drug products

    Abstract

    2.1 Introduction

    2.2 Common techniques used for the construction of EPDs

    2.3 The peptide drug pramlintide

    2.4 Monoclonal antibodies at low and high concentration

    2.5 Static vs. dynamic EPDs: a case study using a humanized immunoglobulin (IgG1)

    2.6 Conclusion and future studies

    Chapter 3: Properties of protein formulations

    Abstract

    3.1 Introduction

    3.2 Opalescence

    3.3 Phase separation

    3.4 Color

    3.5 Subvisible particles

    Chapter 4: Material and process compatibility testing

    Abstract

    4.1 Introduction

    4.2 Material compatibility

    4.3 Process compatibility testing

    4.4 Antimicrobial preservative compatibility testing

    Chapter 5: Compounding and filling: drug substance to drug product

    Abstract

    5.1 Introduction

    5.2 Aseptic processing

    5.3 Bulk drug substance

    5.4 Compounding of drug product

    5.5 Filling the drug product

    Chapter 6: Administration in the clinic

    Abstract

    6.1 Introduction and background

    6.2 Diluents

    6.3 Components

    6.4 Construction materials

    6.5 Clinical dosing strategy: fixed volume versus fixed concentration

    6.6 Representative admixture concentration levels

    6.7 Exposure temperature and time

    6.8 Option of using syringes

    6.9 Analytical tests and acceptance criteria

    6.10 Sample preparation considerations

    6.11 Role of probe studies

    6.12 Bag overfill volume

    6.13 Pharmacy instructions

    6.14 Conclusions

    Chapter 7: Regulatory guidelines for the development of a biotechnology drug product

    Abstract

    7.1 Introduction

    7.2 ICH overview

    7.3 Common Technical Document (CTD)

    7.4 Drug product dossier

    7.5 Regulatory considerations through the biotechnology product lifecycle

    7.6 Conclusions

    Appendix

    Recommended reading

    Index

Product details

  • No. of pages: 200
  • Language: English
  • Copyright: © Woodhead Publishing 2012
  • Published: January 2, 2012
  • Imprint: Woodhead Publishing
  • Hardcover ISBN: 9781907568183
  • eBook ISBN: 9781908818102

About the Editor

Brian Meyer

Dr Brian K. Meyer is a Research Fellow in Bioprocess Research and Development, Merck Research Laboratories (MRL). Dr Meyer's current position is leading a group in Vaccine Drug Product Development. Previously, Dr Meyer's team was responsible for formulating therapeutic proteins in pre-clinical development. Prior to joining MRL, Dr Meyer was a Process Scientist in Vaccine Technology and Engineering, Merck Manufacturing Division. He has a Ph.D. in Biochemistry, Microbiology, and Molecular Biology from The Pennsylvania State University and a B.S.E. in Biomedical Engineering from Tulane University.

Affiliations and Expertise

Merck Research Laboratories (MRL), USA

Ratings and Reviews

Write a review

There are currently no reviews for "Therapeutic Protein Drug Products"